Company: NGVT
Filing Date: 2025-11-06
Form Type: 10-Q
Source: 0001653477-25-000127
Chunk: 98

Company: Ingevity Corp
Filing Date: 2025-11-06
Form: 10-Q
Item: Part I, Item 8
Chunk 98
---
Other comprehensive income (loss), net of tax— 0.1 — 0.1 Ending balance$2.5 $0.6 $2.5 $0.6 Total AOCI ending balance at September 30$(2.4)$(3.5)$(2.4)$(3.5)

20

INGEVITY CORPORATIONNotes to the Condensed Consolidated Financial StatementsSeptember 30, 2025(Unaudited)

Reclassifications of accumulated other comprehensive income (loss)Three Months Ended September 30,Nine Months Ended September 30,In millions2025202420252024Derivative instrumentsCurrency exchange contracts (1)$(0.1)$— $(0.3)$— Natural gas contracts (2)0.3 (0.8)0.2 (2.3)Total before tax0.2 (0.8)(0.1)(2.3)(Provision) benefit for income taxes(0.1)0.1 — 0.5 Amount included in net income (loss)$0.1 $(0.7)$(0.1)$(1.8)Pension and other post retirement benefitsAmortization of prior service costs (2)$— $(0.1)$— $(0.1)Total before tax— (0.1)— (0.1)(Provision) benefit for income taxes— — — — Amount included in net income (loss)$— $(0.1)$— $(0.1)_______________(1) Included within "Net sales" on the condensed consolidated statements of operations.(2) Included within "Cost of sales" on the condensed consolidated statements of operations.Share RepurchasesOn July 25, 2022, our Board of Directors authorized the repurchase of up to $500.0 million of our common stock (the "2022 Authorization"), and rescinded the prior outstanding repurchase authorization with respect to the shares that remained unused under the prior authorization. Shares under the 2022 Authorization may be purchased through open market or privately negotiated transactions at the discretion of management based on its evaluation of market prevailing conditions and other factors, including through the use of trading plans intended to qualify under Rule 10b5-1 under the Securities Exchange Act of 1934, as amended.During the three and nine months ended September 30, 2025, we repurchased $